CG Oncology
Bobby Fredin currently serves as the Associate Director of CMC, Process Development, and MSAT at CG Oncology since December 2023, and has held the position of CEO at Coastal Biologics Consulting LLC since January 2023. Prior to these roles, Bobby Fredin amassed significant experience at MilliporeSigma from November 2003 to October 2023, progressing through various titles including Senior Manager of Client Technical Services, Manager of Process Development, Principal Scientist, and Senior Scientist in Process Development. Bobby Fredin holds a Bachelor of Science degree in Biochemistry and Molecular Biology from California State University San Marcos.
This person is not in the org chart
This person is not in any teams
This person is not in any offices